Akari Therapeutics Cash from Financing (Quarterly) Insights

Akari Therapeutics PLC (AKTX)

2.79 -0.87 (-23.77%) USD | NASDAQ | Jun 25, 16:00

2.79 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2014. Upgrade now.

Date	Value
March 31, 2024	1.514M
June 30, 2023	0.2908M
March 31, 2023	3.212M
June 30, 2022	0.00
March 31, 2022	12.37M
December 31, 2021	1.116M
September 30, 2021	11.18M
June 30, 2021	1.994M
March 31, 2021	0.00
December 31, 2020	5.992M
September 30, 2020	0.00
June 30, 2020	9.204M
March 31, 2020	9.878M
December 31, 2019	2.776M
September 30, 2019	8.398M
June 30, 2019	1.316M
March 31, 2019	0.1577M
December 31, 2018	0.1534M
September 30, 2018	0.3466M

Date	Value
June 30, 2018	0.00
March 31, 2018	0.00
December 31, 2017	15.67M
September 30, 2017	0.00
June 30, 2017
March 31, 2017
December 31, 2016
September 30, 2016
June 30, 2016
March 31, 2016
December 31, 2015	-3.060M
September 30, 2015	72.61M
June 30, 2015	-0.5087M
March 31, 2015
December 31, 2014	3.893M
September 30, 2014	-7.877M
June 30, 2014	0.00
March 31, 2014	8.219M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

Minimum

Sep 2020

12.37M

Maximum

Mar 2022

4.328M

Average

2.385M

Median

Cash from Financing (Quarterly) Benchmarks

DBV Technologies SA	-0.062M
Cellectis SA	11.90M
Adaptimmune Therapeutics PLC	29.24M
Biodexa Pharmaceuticals Plc	--
Verona Pharma PLC	-3.123M

Cash from Financing (Quarterly) Related Metrics

Cash from Operations (Quarterly)	-4.044M
Free Cash Flow	-22.19M
Free Cash Flow Per Share (Quarterly)	-0.6012
Free Cash Flow Yield	-171.7%